Taxus “Peri-approval” Trial Offers Postmarket Study Model – Zuckerman

FDA is encouraging PMA sponsors to file a continued-access protocol for a long-term trial that will meet postmarket study requirements following a device's approval

More from Archive

More from Medtech Insight